MLTX
MoonLake Immunotherapeutics (MLTX)
$34
About MoonLake Immunotherapeutics (MLTX)
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.
Details
Daily high
$15.36
Daily low
$14.26
Price at open
--
52 Week High
$62.75
52 Week Low
$5.95
Market cap
1.1B
Dividend yield
0.00%
Volume
194
Avg. volume
2.0M
P/E ratio
-4.61
MoonLake Immunotherapeutics News
Details
Daily high
$15.36
Daily low
$14.26
Price at open
--
52 Week High
$62.75
52 Week Low
$5.95
Market cap
1.1B
Dividend yield
0.00%
Volume
194
Avg. volume
2.0M
P/E ratio
-4.61